Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (411-420 of 455) with videos related to

Pageof 46
Sort By:
European Thyroid Journal|October 19, 2023
Hypothyroid women have persistently higher oxidative stress compared to healthy controlsKamilla R Riis, Camilla B Larsen, Bjarke R Medici, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 20, 2017
A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metaboliteNicolai J Wewer Albrechtsen, Ali Asmar, Frederik Jensen, et al.
European Journal of Endocrinology|April 29, 2024
Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetesCoco M Fuhri Snethlage, Abraham S Meijnikman, Anne Linde Mak, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 5, 2020
Parenteral nutrition impairs plasma bile acid and gut hormone responses to mixed meal testing in lean healthy menEmma C E Meessen, Guido J Bakker, Max Nieuwdorp, et al.
Diabetologia|July 19, 2015
Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetesNicolai A Rhee, Camilla D Wahlgren, Jens Pedersen, et al.
Diabetologia|September 18, 2025
Using glucagon receptor antagonism to evaluate the physiological effects of extrapancreatic glucagon in totally pancreatectomised individuals: a randomised controlled trialCaroline Trunk-Black Juel, Asger B Lund, Sofie Hædersdal, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 3, 2024
Weight Loss for Patients With Gout and Concomitant Obesity: A Proof-of-Concept Randomized TrialRobin Christensen, Kristian Zobbe, Sabrina M Nielsen, et al.
Diabetes|January 11, 2019
Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy IndividualsLærke S Gasbjerg, Mads M Helsted, Bolette Hartmann, et al.
Diabetes, Obesity & Metabolism|December 29, 2025
Glucose-dependent insulinotropic polypeptide reduces postprandial glucose excursions but does not protect from hypoglycaemia in persons with type 1 diabetes-A randomised placebo-controlled studyBjørn Hoe, Sebastian M N Heimbürger, Lærke S Gasbjerg, et al.
Neurogastroenterology and Motility|August 11, 2021
Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplastyMaria S Svane, Caroline C Øhrstrøm, Astrid Plamboeck, et al.
Pageof 46

Showing results (411-420 of 455) with videos related to

Sort By:
Pageof 46
European Thyroid Journal|October 19, 2023
Hypothyroid women have persistently higher oxidative stress compared to healthy controlsKamilla R Riis, Camilla B Larsen, Bjarke R Medici, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 20, 2017
A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metaboliteNicolai J Wewer Albrechtsen, Ali Asmar, Frederik Jensen, et al.
European Journal of Endocrinology|April 29, 2024
Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetesCoco M Fuhri Snethlage, Abraham S Meijnikman, Anne Linde Mak, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 5, 2020
Parenteral nutrition impairs plasma bile acid and gut hormone responses to mixed meal testing in lean healthy menEmma C E Meessen, Guido J Bakker, Max Nieuwdorp, et al.
Diabetologia|July 19, 2015
Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetesNicolai A Rhee, Camilla D Wahlgren, Jens Pedersen, et al.
Diabetologia|September 18, 2025
Using glucagon receptor antagonism to evaluate the physiological effects of extrapancreatic glucagon in totally pancreatectomised individuals: a randomised controlled trialCaroline Trunk-Black Juel, Asger B Lund, Sofie Hædersdal, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 3, 2024
Weight Loss for Patients With Gout and Concomitant Obesity: A Proof-of-Concept Randomized TrialRobin Christensen, Kristian Zobbe, Sabrina M Nielsen, et al.
Diabetes|January 11, 2019
Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy IndividualsLærke S Gasbjerg, Mads M Helsted, Bolette Hartmann, et al.
Diabetes, Obesity & Metabolism|December 29, 2025
Glucose-dependent insulinotropic polypeptide reduces postprandial glucose excursions but does not protect from hypoglycaemia in persons with type 1 diabetes-A randomised placebo-controlled studyBjørn Hoe, Sebastian M N Heimbürger, Lærke S Gasbjerg, et al.
Neurogastroenterology and Motility|August 11, 2021
Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplastyMaria S Svane, Caroline C Øhrstrøm, Astrid Plamboeck, et al.
Pageof 46